Q4 2025. Management View. CEO Bret Christensen described 2025 as a pivotal year marked by “important changes to the Biote team, our pr ...

COLUMBUS, GA, UNITED STATES, March 3, 2026 /EINPresswire.com/ -- OBGYN Specialists of Columbus is helping women better ...

IRVING, Texas--(BUSINESS WIRE)--Delivering testosterone via bioabsorbable pellets inserted under the skin is a low-risk approach to long-term hormone therapy for women and men, according to ...

biote Corp. (NASDAQ:BTMD) Q4 2025 Earnings Call Transcript March 11, 2026 biote Corp. beats earnings expectations. Reported EPS is $0.06339, expectations were $0.04. Operator: Good day, and welcome to ...

A focus on training and optimizing middle management are the keys to her success. To say Terry Weber has had a diverse career path is an absolute understatement. With successful leadership roles ...

Biote (NASDAQ: BTMD), a leader in innovative hormone optimization and healthy aging solutions that advance the healthspan of our practitioners’ patients, today announced financial results for the ...

Biote Corp. (NASDAQ:BTMD) announced Monday that its wholly owned subsidiary, F.H. Investments, Inc., doing business as Asteria Health, has initiated a voluntary recall of certain lots of compounded ...

BEAUMONT, Texas — One Beaumont woman is thanking a tiny pellet filled with testosterone for turning her life around. For most of her life, Virginia Coleman struggled with a hormone imbalance, and she ...